PharmaCyte Biotech, Inc. - PMCB

About Gravity Analytica
Recent News
- 03.18.2026 - 4 - Statement of changes in beneficial ownership of securities
- 03.18.2026 - SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 03.17.2026 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 03.09.2026 - ARS - Annual Report to Security Holders
- 03.09.2026 - DEF 14A - Definitive proxy statements
- 02.27.2026 - PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition
- 02.13.2026 - SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors
- 01.27.2026 - CORRESP - Correspondence
- 01.27.2026 - UPLOAD - SEC-generated letter
- 01.07.2026 - 4 - Statement of changes in beneficial ownership of securities
Recent Filings
- 03.09.2026 - DEF 14A Other definitive proxy statements
- 03.09.2026 - ARS Annual Report to Security Holders
- 02.27.2026 - PRE 14A Other preliminary proxy statements
- 02.13.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 12.18.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]